Vera Marisa Costa

Vera Marisa Costa (VMC) has completed her PhD in Toxicology in 2009/06/23 in the University of Porto (Faculty of Pharmacy (FFUP).) She is at present an Auxiliary Researcher in Universidade do Porto, Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares under Norma Transitória and Toxicology Lecturer at FFUP. VMC has a long pedagogic experience in several Universities, mainly on the Pharmacology and Toxicology field. At present, VMC has published 87 full articles in International Journals with Peer Review, mostly in Journals of Q1 on their respective fields. VMC is Associate Editor on three International Journals, by invitation: Brazilian Journal of Pharmaceutical Sciences, since 2019, Cardiovascular Toxicology (Springer-Nature Publishing) since 2020, and Frontiers in Toxicology - Clinical Toxicology since 2022. VMC has participated in the organization of 4 scientific events, of which one international and colaborates in Graduate Program of Bioexperimentação, Universidade of Passo Fundo, Brazil. Her works impacts on Medical and Health Sciences with emphasis on Pharmacology, Pharmacy and Toxicology, maily focusing on Onco-Cardiology, Chemobrain and Toxin Toxicity. She was the principal investigator (PI) of two FCT funded projects on cardioncology: Why is mitoxantrone a poison to the heart? Focus on mitochondria, cytoskeleton, and metabolic bioactivation mechanisms (EXPL/DTP-FTO/0290/2012) and Poisoning the heart with anticancer drugs: is metabolic bioactivation or aging promotion the link to the cardiotoxicity of anticancer drugs? (PTDC/DTPFTO/1489/2014), with participation on several others as researcher, one of them international and EU funded. She also participitated in COST action, CA16225 - Realising the therapeutic potential of novel cardioprotective therapies and is presently involved as member in another: Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases¿ (BenBedPhar) CA20121. VMC has been an Evaluator of Scientific Projects of the Italian Ministry for University Research (MUR) since 2020, of the Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) of Romania and of the Science Fund of the Republic of Serbia since 2021, being that in the latter she was also Lead Reviewer. She presently is enrolled on the List of expert candidates of the Smart Growth Operational Programme of the Foundation for Polish Science. She is presently the (co)supervisor of 5 PhD students. VMC has (co)supervised three PhD students that have successfully accomplished their works and she has (co)supervised 12 MSc dissertation(s) (plus 3 are ongoing). She presently maintains active international collaborations with Kurt J Varner (Louisiana, USA), Premysl Mladenka (Charles University, Czech Republic) and Alessandro Colombo (Milan, Italy) and in her curriculum Ciência Vitae the most frequent terms in the context of scientific outputs are: chemotherapy, cardio-oncology, toxicology; catecolamines; doxorubicin; cardiac cells; in vivo; oxidative stress; amanitin; RNA polymerase II; oncology; antidotes; hepatotoxicity; MDMA; amphetamines; cathinones; chemobrain.